Issue: Volume XIX No. 18 - December 31, 2012

Finding Lab Growth Opportunities Amid the Gloom

IN MANY WAYS, THE TRADITIONAL BUSINESS MODELS for laboratory testing services are proving deficient in the face of a swiftly-evolving healthcare system. I suspect that none of us fully understand how many laboratory organizations are already under extreme financial stress. We intuitively understand that, somewhere out in the healthcare marketplace, clever and innovative pathologists are …

Finding Lab Growth Opportunities Amid the Gloom Read More »

Price Cuts, Long Delays in Payment Are Expected

CEO SUMMARY: In addition to a steep cut in the 88305 CPT code, anatomic pathology laboratories can expect cuts in the payment from Medicare for molecular and prostate biopsy testing. Two national experts in lab billing and reimbursement warn labs to expect confusion in how both public and private payers implement these new policies. Overall, …

Price Cuts, Long Delays in Payment Are Expected Read More »

Ascend Clinical Acquires PathCentral Lab Business

CEO SUMMARY: Ascend Clinical and PathCentral see an opportunity to provide sophisticated services to community pathology groups. Ascend Clinical will expand the molecular diagnostic and gene sequencing business it is purchasing from PathCentral. PathCentral will concentrate on marketing its cloud-based anatomic pathology LIS solution and launching a pathology professional network early in 2013. Each company …

Ascend Clinical Acquires PathCentral Lab Business Read More »

Preserving Competition Is Goal of California Lawsuit

CEO SUMMARY: Once again, the use of deeply-discounted lab test pricing to win exclusive managed care contracts is involved in a court case. However, this latest private lawsuit is different from earlier cases because it seeks to preserve competition in the lab testing and the managed care contracting marketplaces, said an attorney for the four …

Preserving Competition Is Goal of California Lawsuit Read More »

Dark Daily

December 31, 2012 “Intelligence: Late Breaking Lab News”

It is likely that the latest lab acquisition by Bio-Reference Laboratories, Inc. (BRLI) is for the purpose of building its new Hispanic laboratory business, called Laboratorio Buena Salud. Earlier this month, BRLI announced an agreement to purchase Meridian Clinical Laboratory Corporation, located in Miami, Florida. It’s a small transaction, with a price of approximately $1.85 million. …

December 31, 2012 “Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.